Wellington Management Group LLP Invests $1.36 Million in Bruker Corporation $BRKR

Wellington Management Group LLP purchased a new position in shares of Bruker Corporation (NASDAQ:BRKR) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 22,683 shares of the medical research company’s stock, valued at approximately $1,365,000.

Other institutional investors also recently added to or reduced their stakes in the company. Allworth Financial LP increased its position in Bruker by 40.6% during the 3rd quarter. Allworth Financial LP now owns 890 shares of the medical research company’s stock worth $29,000 after purchasing an additional 257 shares during the period. Federated Hermes Inc. lifted its holdings in shares of Bruker by 6.7% in the 4th quarter. Federated Hermes Inc. now owns 6,027 shares of the medical research company’s stock valued at $284,000 after buying an additional 380 shares during the period. Parallel Advisors LLC lifted its holdings in shares of Bruker by 121.0% in the 4th quarter. Parallel Advisors LLC now owns 875 shares of the medical research company’s stock valued at $41,000 after buying an additional 479 shares during the period. State of Michigan Retirement System boosted its stake in shares of Bruker by 1.9% in the first quarter. State of Michigan Retirement System now owns 26,693 shares of the medical research company’s stock valued at $964,000 after buying an additional 500 shares in the last quarter. Finally, Los Angeles Capital Management LLC acquired a new position in Bruker during the fourth quarter worth $26,000. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Barclays upped their target price on shares of Bruker from $53.00 to $60.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. Zacks Research lowered Bruker from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 2nd. Wolfe Research assumed coverage on shares of Bruker in a research note on Monday, June 1st. They issued a “peer perform” rating for the company. Guggenheim upped their target price on shares of Bruker from $50.00 to $70.00 and gave the company a “buy” rating in a report on Monday, June 29th. Finally, Leerink Partners raised their price target on shares of Bruker from $60.00 to $70.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 7th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Bruker has an average rating of “Hold” and a consensus target price of $57.00.

Bruker Stock Down 0.2%

BRKR opened at $53.43 on Friday. The firm has a 50 day moving average price of $58.25 and a 200 day moving average price of $49.25. The company has a market cap of $8.14 billion, a PE ratio of -76.33, a price-to-earnings-growth ratio of 1.64 and a beta of 1.26. Bruker Corporation has a 1 year low of $30.09 and a 1 year high of $65.30. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.92 and a current ratio of 1.85.

Bruker (NASDAQ:BRKR) last posted its earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.11. The business had revenue of $838.50 million for the quarter, compared to analyst estimates of $853.57 million. Bruker had a negative net margin of 2.35% and a positive return on equity of 12.47%. The business’s quarterly revenue was up 5.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.32 EPS. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. Sell-side analysts expect that Bruker Corporation will post 2.12 earnings per share for the current year.

Bruker Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, October 7th. Investors of record on Monday, September 21st will be issued a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.4%. The ex-dividend date of this dividend is Monday, September 21st. Bruker’s dividend payout ratio (DPR) is presently -28.57%.

Bruker Company Profile

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company’s product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.